Shanghai Huiying Medical Technology
A multinational enterprise focusing on the research, development, production and global sales of tumor radiotherapy medical device technology
About Shanghai Huiying Medical Technology
BEBIG Medical Group specializes in providing innovative brachytherapy solutions for cancer treatment. Operating in the medical technology sector, the company serves healthcare providers and hospitals globally. BEBIG Medical Group's core product offerings include high-dose-rate (HDR) brachytherapy systems, which are used to deliver precise radiation therapy to cancer patients. The company generates revenue through the sale of its medical devices and related services, including maintenance and support. By focusing on advanced technology and patient outcomes, BEBIG Medical Group aims to improve the effectiveness and efficiency of cancer treatments.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 15.0/100
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Jan 2024 | $14M | $55M | Cathay Venture | ↗ |
| SERIES AEquity / VC | Mar 2021 | $0 | — | Cathay Capital | ↗ |
Growth signals
Latest recorded traffic for Shanghai Huiying Medical Technology is 340 monthly website visits, up 240% over the last three months.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Shanghai Huiying Medical Technology in its local ecosystem
The Shanghai Huiying Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Cathay Capital
Cathay Venture
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shanghai Huiying Medical Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shanghai Huiying Medical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.